Shockwave has been making waves this summer! As you dive into this edition of the PulsePoint Newsletter, you’ll see that JACC: Cardiovascular Interventions published a trilogy of peer-reviewed publications highlighting Shockwave’s MOA, a pooled analysis of the 4 Disrupt CAD studies, and Disrupt PAD lll. Dive deeper and you’ll discover the incredible 10-webinar series called Calcium Masterclass that was launched at the beginning of the quarter. Explore how Shockwave was granted transitional pass-through reimbursement for Coronary IVL and proposed additional payment for hospital in-patient Coronary IVL cases performed in the United States. This PulsePoint has a lot to cover – recap the rest of the events and milestones from an exciting last quarter. But as you relax on your vacation, always stay on the pulse!
Read More
Topics:
Coronary IVL,
IVL Case,
Peripheral IVL,
IVL Technology,
Coronary Cases,
Peripheral Cases,
Shockwave C2,
Shockwave M5,
Shockwave S4,
PulsePoint Newsletter,
Coronary IVL - U.S.
Treatment of nodular calcium in coronary PCI remains a challenge, even for the most skilled operators. Recently, CRT 2021 Virtual featured a live case from Medstar Washington Hospital Center in Washington, DC with nodular calcium from operators Hayder D. Hashim, MD, and Lowell F. Satler, MD, who were joined by an expert panel led by Ron Waksman, MD. During the case the physicians discussed and debated treatment strategies to address nodular calcium, deciding in this case for coronary IVL, which resulted from a baseline MLA of 1.6mm2 to a post-IVL MLA of 4.9mm2 to a post-DES MSA of 7.2mm2.
Read More
Topics:
Coronary IVL,
Coronary Cases,
Shockwave C2,
CAD Applications - Eccentric Lesions,
CAD Applications - Bifurcations,
Coronary IVL - U.S.
If you missed the two Shockwave IVL sessions at EuroPCR 2021, or would like to watch the symposia again, you’re in luck. The Shockwave IVL content from EuroPCR 2021 is available here.
Read More
Topics:
Medical Meetings,
Coronary Cases,
Coronary Clinical Data,
Shockwave C2,
Coronary Conferences
PulsePoint is back! Bringing you a highlight reel of the most memorable moments, successes and key events of Q1 for both our coronary and peripheral technology. Most notably, Shockwave had a history-making moment in February of this year when we received FDA approval in the U.S. for Coronary IVL! Since then, we have seen many physicians achieving great success utilizing the technology. We also brought a new podcast, ChalkTalk, to life, and so much more we want to share with you. Check out the latest PulsePoint for the full scoop!
Read More
Topics:
Coronary IVL,
IVL Case,
Peripheral IVL,
IVL Technology,
Coronary Cases,
Peripheral Cases,
Shockwave C2,
Shockwave M5,
Shockwave S4,
PulsePoint Newsletter,
Coronary IVL - U.S.
We had the privilege of connecting with Dr. Robert Riley Director, Complex Coronary Therapeutics Program, The Christ Hospital Health System. Dr. Riley is the leading author of the abstract for the Patient-Level Pooled Analysis of the Disrupt CAD I, II, III and IV studies and presented at ACC.21 Virtual.
Read More
Topics:
Coronary IVL,
DISRUPT CAD,
Coronary Cases,
Coronary Clinical Data,
Shockwave C2,
Coronary Conferences
You know the expression – “the more things change, the more they stay the same.” Well if there’s anything that we learned over the last year, it’s that this phrase absolutely does not apply to anything related to IVL.
Read More
Topics:
Medical Meetings,
Coronary Cases,
Coronary Clinical Data,
Shockwave C2,
Coronary Conferences
One cannot become a calcium expert overnight – it takes time and commitment to go deep on the topic. That’s why we’re excited to embark this month on a year-long education journey that we’re calling the Calcium Masterclass. Over the last year, we’ve been working with Prof. James Spratt (St. George’s University, London) and the team at Optima Education to develop a comprehensive collection of 10 webinars, 5 of which will feature live cases, and a 14-chapter calcium compendium that will be presented by 37 masters of coronary calcium.
Read More
Topics:
Coronary IVL,
Coronary Cases,
Shockwave C2,
CAD Applications - Eccentric Lesions,
CAD Applications - Bifurcations,
Coronary IVL - U.S.
Following the recent PMA approval of coronary IVL, Dr. Robert Riley, Medical Director of the Complex Coronary Therapeutics Program, and Dr. John Corl, Medical Director of PAD/CLI Program, of the Christ Hospital in Cincinnati, performed the first commercial U.S. coronary IVL cases. Following their cases, we caught up with Dr. Riley to get his take on using the technology outside of a clinical trial and what advice he has for other physicians before they try the technology.
Read More
Topics:
Coronary IVL,
IVL Case,
Coronary Cases,
Shockwave C2,
Coronary IVL - U.S.
In case you missed its live airing, tune into a great discussion from coronary IVL’s most knowledgeable operators about how they are treating severely calcified lesions, their tips and tricks using IVL in real world practice as well as their clinical experience with IVL.
Read More
Topics:
Coronary Cases,
Coronary Clinical Data,
Shockwave C2
If an image is worth a thousand words, then we’d have to write a novel to capture all of the key takeaways from the 300 OCT images (i.e. pre-IVL, post-IVL & post-DES) that were taken from the 100 patients that participated in the Disrupt CAD III OCT sub-analysis. Thankfully, we ditched the novel and opted for an easy-to-digest infographic to capture the 10 most pertinent data points from the OCT study presented at TCT Connect. Happy viewing!
Read More
Topics:
Coronary Cases,
Coronary Clinical Data,
Shockwave C2
